NHS PolicyMartha's Rule Reaches Every A&E: What the NHS-Wide Rollout Means for Emergency Care
A patient safety mechanism born from tragedy is now set to cover every emergency department in England.
VanadiumNews Research Team·5 min read·27 Sept 2026
NHS PolicyPharma & Biotech
FDA Clears First-Ever Gene Therapy for Sanfilippo Syndrome Type A, Raising Hope — and Questions — for UK Families
VanadiumNews Research Team·5 min·26 Sept 2026
Healthcare Finance & M&A
Johnson & Johnson Secures Option to Acquire In Vivo CAR-T Pioneer Sail in Up-to-$2.6bn Deal
VanadiumNews Research Team·4 min·30 Jul 2026
Lilly's Retatrutide Clears Phase 3 Obesity Hurdles but Cardiovascular Benefit Remains Unproven
VanadiumNews Research Team·5 min·26 Jul 2026
BGO's £750m Whitechapel Campus Bid Signals Growing Investor Appetite for NHS-Adjacent Real Estate
VanadiumNews Research Team·4 min·22 Jul 2026
Latest
£54m Thrive Centre Takes Shape in Salford, Blending Clinical Research with Next-Generation Health Education
Premium4 min·16 Aug 2026
FDA Clears First Narcolepsy Type 1 Drug to Target the Full Symptom Spectrum — What It Means for UK Patients
Premium4 min·15 Aug 2026
Scancell Secures Nasdaq Route Via Reverse Merger With Neuphoria as UK Oncology Biotech Eyes US Capital Markets
4 min·26 Jul 2026
UKHSA Issues Eye Safety Warning Ahead of August 2026 Partial Solar Eclipse
4 min·24 Jul 2026
Government Commits £3.2m to One-Day MSK Clinics in Bid to Cut Workforce Inactivity
4 min·22 Jul 2026
EMA Accelerates Review of Daraxonrasib as Pancreatic Cancer Drug Enters Rolling Evaluation
4 min·22 Jul 2026
Non-Opioid Pain Specialist Latigo Biosciences Files for Nasdaq IPO Amid Biotech Listing Revival
4 min·22 Jul 2026
J&J and Time Magazine Launch Healthcare Champion Award in High-Profile Industry Partnership
4 min·21 Jul 2026
US Clinic and Practice Bankruptcies Surge in 2026 — and the Ripple Effects Could Reach UK Health Markets
4 min·21 Jul 2026
Most read
0102030405
Merck Secures Historic First Approval for Oral PCSK9 Inhibitor, Reshaping the Cholesterol Drug Market
Healthcare Finance & M&ANHS Fast-Tracks AI Deployment Across Services in Bid to Tackle Waiting Lists
NHS PolicyFDA Extends Casgevy Approval to Children Aged Two and Over, Raising Hopes and Questions for NHS Access
Pharma & BiotechWHO Clears First Diagnostic Test for Bundibugyo Ebola Strain, Closing a Critical Gap in Outbreak Detection
Global Health MarketsCHMP Backs Six New Medicines in June 2026 Session, Including Weekly Insulin and Rare Paediatric Drug
Pharma & BiotechThe Vanadium Brief
Every Monday, the definitive read on healthcare markets — capital flows, policy shifts, and what they mean for the boardroom.
About VanadiumNews
VanadiumNews is an independent business intelligence publication for the healthcare leadership community, operated by Vanadium Media Group.
The site publishes original reporting and analysis across five sections — NHS & Policy, Private Healthcare, MedTech, Pharma & Biotech, and Finance & M&A — with newsroom contributions from London. Anyone can read our journalism on vanadiumnews.com without an account.
What you can do with a free account
- Save articles to a personal reading library
- Get a personalized homepage feed based on the sections you follow
- Subscribe to and manage editorial newsletters
- Sync reading progress across devices
- Optionally upgrade to a premium subscription for paywalled analysis
Signing in with Google
We offer Google Sign-In purely to authenticate your account. When you sign in, Google shares three pieces of profile information with us:
- Name — shown on your account and any comments you post.
- Email address — used as your account identifier and, if you opt in, to deliver newsletters.
- Profile picture — displayed as your avatar.
We do not access your Gmail, Google Drive, Calendar, or any other Google service, and we do not sell your personal information. Full details are in our Privacy Policy and Terms of Service.